Total Payments
$4,328
2024 Payments
$1,312
Companies
20
Transactions
95
Medicare Patients
457
Medicare Billing
$31,325
Payment Breakdown by Category
Food & Beverage$4,328 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,328 | 95 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $1,110 | 37 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $535.26 | 10 | $0 (2024) |
| ABBVIE INC. | $486.03 | 9 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $270.23 | 6 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $263.41 | 3 | $0 (2024) |
| GlaxoSmithKline, LLC. | $233.71 | 5 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $223.51 | 3 | $0 (2023) |
| Axsome Therapeutics, Inc. | $193.74 | 2 | $0 (2024) |
| Daiichi Sankyo Inc. | $184.11 | 1 | $0 (2021) |
| Biohaven Pharmaceuticals, Inc. | $123.48 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,312 | 32 | AstraZeneca Pharmaceuticals LP ($327.43) |
| 2023 | $1,178 | 25 | Novo Nordisk Inc ($320.21) |
| 2022 | $892.33 | 17 | Novo Nordisk Inc ($222.20) |
| 2021 | $945.70 | 21 | Novo Nordisk Inc ($346.77) |
All Payment Transactions
95 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/05/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: Respiratory | ||||||
| 12/05/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $7.03 | General |
| Category: Diabetes | ||||||
| 12/04/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $17.69 | General |
| Category: Respiratory | ||||||
| 12/03/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $11.00 | General |
| Category: Diabetes | ||||||
| 11/19/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $23.90 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/13/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $14.83 | General |
| Category: Diabetes | ||||||
| 11/11/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.98 | General |
| Category: Respiratory | ||||||
| 11/09/2024 | Alnylam Pharmaceuticals Inc. | AMVUTTRA (Drug) | Food and Beverage | In-kind items and services | $55.56 | General |
| Category: Genetic Disease | ||||||
| 10/15/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $18.01 | General |
| Category: Respiratory | ||||||
| 10/14/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $18.33 | General |
| Category: PAIN | ||||||
| 09/30/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $15.80 | General |
| Category: Diabetes | ||||||
| 09/26/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $68.90 | General |
| Category: PSYCHIATRY | ||||||
| 09/24/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $121.82 | General |
| Category: Respiratory | ||||||
| 09/23/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $13.50 | General |
| Category: Respiratory | ||||||
| 09/19/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $91.00 | General |
| Category: RESPIRATORY | ||||||
| 09/04/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.55 | General |
| Category: RESPIRATORY | ||||||
| 08/28/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $18.86 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/27/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $6.33 | General |
| Category: Diabetes | ||||||
| 08/15/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $60.73 | General |
| Category: Central Nervous System | ||||||
| 08/12/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $25.25 | General |
| Category: NEUROSCIENCE | ||||||
| 08/12/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $4.59 | General |
| Category: Diabetes | ||||||
| 06/03/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $13.26 | General |
| Category: Diabetes | ||||||
| 05/15/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $15.66 | General |
| Category: Cardio-renal | ||||||
| 05/14/2024 | Axsome Therapeutics, Inc. | Sunosi (Drug) | Food and Beverage | In-kind items and services | $79.64 | General |
| Category: Neurology | ||||||
| 04/30/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $114.10 | General |
| Category: Psychology/Psychiatric | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 78 | 95 | $9,433 | $4,742 |
| 2022 | 2 | 64 | 67 | $7,680 | $3,998 |
| 2021 | 5 | 121 | 134 | $14,348 | $7,310 |
| 2020 | 8 | 194 | 239 | $32,442 | $15,275 |
Total Patients
457
Total Services
535
Medicare Billing
$31,325
Procedure Codes
20
All Medicare Procedures & Services
20 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 21 | 21 | $2,927 | $1,496 | 51.1% |
| 99284 | Emergency department visit with moderate level of medical decision making | Facility | 2023 | 15 | 15 | $2,175 | $981.65 | 45.1% |
| 99221 | Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | Facility | 2023 | 17 | 19 | $1,888 | $942.86 | 49.9% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 13 | 28 | $1,363 | $821.86 | 60.3% |
| 99283 | Emergency department visit with low level of medical decision making | Facility | 2023 | 12 | 12 | $1,080 | $500.11 | 46.3% |
| 99284 | Emergency department visit for problem of high severity | Facility | 2022 | 29 | 30 | $4,350 | $2,317 | 53.3% |
| 99283 | Emergency department visit for problem of moderate severity | Facility | 2022 | 35 | 37 | $3,330 | $1,681 | 50.5% |
| 99284 | Emergency department visit, problem of high severity | Facility | 2021 | 25 | 25 | $3,625 | $2,058 | 56.8% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 21 | 22 | $3,614 | $1,867 | 51.7% |
| 99283 | Emergency department visit, moderately severe problem | Facility | 2021 | 40 | 44 | $3,960 | $1,841 | 46.5% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 19 | 27 | $2,189 | $1,171 | 53.5% |
| 99282 | Emergency department visit, low to moderately severe problem | Facility | 2021 | 16 | 16 | $960.00 | $372.71 | 38.8% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 37 | 40 | $9,166 | $5,182 | 56.5% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 32 | 68 | $5,513 | $3,206 | 58.2% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2020 | 27 | 30 | $4,181 | $2,090 | 50.0% |
| 99284 | Emergency department visit, problem of high severity | Facility | 2020 | 26 | 26 | $4,757 | $2,032 | 42.7% |
| 99285 | Emergency department visit, problem with significant threat to life or function | Facility | 2020 | 11 | 11 | $3,739 | $1,297 | 34.7% |
| 99283 | Emergency department visit, moderately severe problem | Facility | 2020 | 34 | 37 | $3,330 | $1,200 | 36.0% |
| 99282 | Emergency department visit, low to moderately severe problem | Facility | 2020 | 12 | 12 | $720.00 | $202.21 | 28.1% |
| 93042 | Interpretation and report of electrical activity of heart using 1-3 leads | Facility | 2020 | 15 | 15 | $1,035 | $65.50 | 6.3% |
About Steven Galvez, CRNP
Steven Galvez, CRNP is a Family healthcare provider based in Greensboro, Alabama. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/13/2006. The National Provider Identifier (NPI) number assigned to this provider is 1457422016.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Steven Galvez, CRNP has received a total of $4,328 in payments from pharmaceutical and medical device companies, with $1,312 received in 2024. These payments were reported across 95 transactions from 20 companies. The most common payment nature is "Food and Beverage" ($4,328).
As a Medicare-enrolled provider, Galvez has provided services to 457 Medicare beneficiaries, totaling 535 services with total Medicare billing of $31,325. Data is available for 4 years (2020–2023), covering 20 distinct procedure/service records.
Ad
Practice Information
- Specialty Family
- Location Greensboro, AL
- Active Since 11/13/2006
- Last Updated 10/30/2013
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1457422016
Products in Payments
- VRAYLAR (Drug) $486.03
- Ozempic (Drug) $411.86
- JARDIANCE (Drug) $263.41
- XARELTO (Drug) $244.92
- AIRSUPRA (Drug) $209.73
- Wegovy (Drug) $193.63
- INJECTAFER (Drug) $184.11
- NURTEC ODT (Drug) $141.81
- BREZTRI (Drug) $138.26
- TRULANCE (Drug) $124.99
- FUROSCIX (Drug) $123.10
- RYBELSUS (Drug) $120.62
- Auvelity (Drug) $114.10
- SUNOSI (Drug) $100.65
- XIFAXAN (Drug) $98.52
- ENTRESTO (Drug) $94.09
- REXULTI (Drug) $93.42
- Repatha (Biological) $93.14
- AREXVY (Drug) $91.00
- Rybelsus (Drug) $89.45
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Greensboro
Deanna May
Family — Payments: $37,679
Family $37,679
Christine Dale
Family — Payments: $9,003
Family $9,003
Takela Anderson, Fnp, FNP
Family — Payments: $7,926
Family $7,926
Dr. Jessica Milford, Dnp, Fnp-Bc, DNP, FNP-BC
Family — Payments: $5,838
Family $5,838
Dr. Katherine Cobb, Fnp-Bc, FNP-BC
Family — Payments: $5,537
Family $5,537
Tonya Cranford, Np-C, NP-C
Family — Payments: $5,231
Family $5,231